Adjuvant chemotherapy for bile duct cancer after surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether giving chemotherapy directly into the liver (HAIC) plus an oral chemo pill (capecitabine) after surgery helps prevent bile duct cancer from coming back, compared to just the pill. It's for people who recently had their cancer completely removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with bile duct or gallbladder cancer that was completely removed by surgery
- You have not had any other cancer treatments (like chemo, radiation, or immunotherapy) before or after your surgery
- You are in good overall health (able to do daily activities)
- Your blood counts and liver/kidney function are within acceptable levels
- You agree to use birth control during the study and for 6 months after (if applicable)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a chemotherapy approach after surgery for bile duct or gallbladder cancers. The goal is to see if giving chemotherapy based on a detailed analysis of your tumor (called 3D-PTA) helps prevent the cancer from coming back.
This trial tests a combination of chemotherapy directly into the liver artery, an immunotherapy drug, and a targeted therapy pill before surgery for a type of bile duct cancer that has a high chance of coming back. The goal is to see if this approach can improve outcomes for patients whose cancer is still removable but has certain high-risk features.
This study compares two chemotherapy approaches for patients whose bile duct or gallbladder cancer has been removed but who have a higher chance of it coming back. One group gets a combination of two chemotherapy drugs through an IV, and the other gets a chemotherapy pill. The goal is to see which treatment better prevents recurrence.
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
This trial tests a personalized cancer vaccine combined with chemotherapy to help prevent bile duct cancer from coming back after surgery. It is for people who had their tumor removed but have a high risk of recurrence.
This trial is testing a treatment plan that first delivers chemotherapy directly into the liver (through a thin tube) along with standard IV chemotherapy. The goal is to shrink the tumor enough to allow for surgery or less aggressive treatment later. It is for people with bile duct or gallbladder cancer that has not spread far.
Hear when a new Malignant Biliary Tract Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.